Bcl-2: Difference between revisions
mNo edit summary |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
Bcl-2 | |||
The Bcl-2 (B-cell lymphoma 2) protein is a key regulator of apoptosis, the process of programmed cell death, which is crucial for maintaining cellular homeostasis and development. Bcl-2 is part of a larger family of proteins known as the Bcl-2 family, which includes both pro-apoptotic and anti-apoptotic members. The balance between these opposing forces determines the fate of the cell. | |||
==Structure== | |||
Bcl-2 is a membrane protein that is primarily located on the outer membrane of mitochondria, but it can also be found on the endoplasmic reticulum and nuclear envelope. The protein is characterized by the presence of Bcl-2 homology (BH) domains, which are critical for its function. These domains allow Bcl-2 to interact with other proteins in the Bcl-2 family, forming heterodimers that can either promote or inhibit apoptosis. | |||
== | ==Function== | ||
Bcl-2 functions as an anti-apoptotic protein, meaning it prevents the initiation of apoptosis. It does so by binding to and sequestering pro-apoptotic proteins such as [[Bax]] and [[Bak]], preventing them from permeabilizing the mitochondrial outer membrane. This action inhibits the release of cytochrome c and other pro-apoptotic factors from the mitochondria, thereby blocking the activation of the caspase cascade that leads to cell death. | |||
[[ | ==Role in Cancer== | ||
The overexpression of Bcl-2 is associated with several types of cancer, including [[B-cell lymphoma]], from which it derives its name. In cancer cells, high levels of Bcl-2 can prevent apoptosis, allowing the cells to survive longer than they should, contributing to tumor growth and resistance to chemotherapy. Targeting Bcl-2 with specific inhibitors, such as [[venetoclax]], has become a therapeutic strategy in treating certain cancers. | |||
== | ==Research and Therapeutic Implications== | ||
Research into Bcl-2 and its family members continues to be a significant area of interest, particularly in understanding the mechanisms of apoptosis and developing new cancer therapies. Bcl-2 inhibitors are being tested in clinical trials for their efficacy in treating various malignancies. | |||
== | ==Also see== | ||
Apoptosis | * [[Apoptosis]] | ||
* [[Bax]] | |||
* [[Bak]] | |||
* [[Mitochondria]] | |||
* [[Venetoclax]] | |||
* [[Cancer]] | |||
{{Apoptosis}} | |||
{{Cancer}} | |||
[[Category:Apoptosis]] | [[Category:Apoptosis]] | ||
[[Category:Proteins]] | |||
[[Category:Oncology]] | |||
<gallery> | |||
File:Bcl2 inhibition of Bax on mitochondrion.png|Bcl-2 inhibition of Bax on mitochondrion | |||
File:Signal transduction pathways.svg|Signal transduction pathways | |||
</gallery> | |||
Latest revision as of 00:49, 20 February 2025
Bcl-2
The Bcl-2 (B-cell lymphoma 2) protein is a key regulator of apoptosis, the process of programmed cell death, which is crucial for maintaining cellular homeostasis and development. Bcl-2 is part of a larger family of proteins known as the Bcl-2 family, which includes both pro-apoptotic and anti-apoptotic members. The balance between these opposing forces determines the fate of the cell.
Structure[edit]
Bcl-2 is a membrane protein that is primarily located on the outer membrane of mitochondria, but it can also be found on the endoplasmic reticulum and nuclear envelope. The protein is characterized by the presence of Bcl-2 homology (BH) domains, which are critical for its function. These domains allow Bcl-2 to interact with other proteins in the Bcl-2 family, forming heterodimers that can either promote or inhibit apoptosis.
Function[edit]
Bcl-2 functions as an anti-apoptotic protein, meaning it prevents the initiation of apoptosis. It does so by binding to and sequestering pro-apoptotic proteins such as Bax and Bak, preventing them from permeabilizing the mitochondrial outer membrane. This action inhibits the release of cytochrome c and other pro-apoptotic factors from the mitochondria, thereby blocking the activation of the caspase cascade that leads to cell death.
Role in Cancer[edit]
The overexpression of Bcl-2 is associated with several types of cancer, including B-cell lymphoma, from which it derives its name. In cancer cells, high levels of Bcl-2 can prevent apoptosis, allowing the cells to survive longer than they should, contributing to tumor growth and resistance to chemotherapy. Targeting Bcl-2 with specific inhibitors, such as venetoclax, has become a therapeutic strategy in treating certain cancers.
Research and Therapeutic Implications[edit]
Research into Bcl-2 and its family members continues to be a significant area of interest, particularly in understanding the mechanisms of apoptosis and developing new cancer therapies. Bcl-2 inhibitors are being tested in clinical trials for their efficacy in treating various malignancies.
Also see[edit]
| Apoptosis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This apoptosis-related article is a stub.
|
| Overview of tumors, cancer and oncology (C00–D48, 140–239) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
-
Bcl-2 inhibition of Bax on mitochondrion
-
Signal transduction pathways